Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

1.

Histological chronic prostatitis and high-grade prostate intra-epithelial neoplasia do not influence urinary prostate cancer gene 3 score.

De Luca S, Passera R, Milillo A, Coda R, Randone DF.

BJU Int. 2012 Dec;110(11 Pt B):E778-82. doi: 10.1111/j.1464-410X.2012.11645.x. Epub 2012 Nov 1.

PMID:
23116408
[PubMed - indexed for MEDLINE]
2.

Fluctuation in prostate cancer gene 3 (PCA3) score in men undergoing first or repeat prostate biopsies.

De Luca S, Passera R, Cappia S, Bollito E, Randone DF, Milillo A, Papotti M, Porpiglia F.

BJU Int. 2014 Jan 28. doi: 10.1111/bju.12654. [Epub ahead of print]

PMID:
24472071
[PubMed - as supplied by publisher]
3.

A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.

Auprich M, Augustin H, Budäus L, Kluth L, Mannweiler S, Shariat SF, Fisch M, Graefen M, Pummer K, Chun FK.

BJU Int. 2012 Jun;109(11):1627-35. doi: 10.1111/j.1464-410X.2011.10584.x. Epub 2011 Sep 21.

PMID:
21939492
[PubMed - indexed for MEDLINE]
4.

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.

Sciarra A, Panebianco V, Cattarino S, Busetto GM, De Berardinis E, Ciccariello M, Gentile V, Salciccia S.

BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.

PMID:
22564540
[PubMed - indexed for MEDLINE]
5.

Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy.

Ochiai A, Okihara K, Kamoi K, Oikawa T, Shimazui T, Murayama S, Tomita K, Umekawa T, Uemura H, Miki T.

BJU Int. 2013 May;111(6):928-33. doi: 10.1111/j.1464-410X.2012.11683.x. Epub 2013 Jan 18.

PMID:
23331404
[PubMed - indexed for MEDLINE]
6.

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA.

Eur Urol. 2008 Nov;54(5):1081-8. doi: 10.1016/j.eururo.2008.06.071. Epub 2008 Jun 26.

PMID:
18602209
[PubMed - indexed for MEDLINE]
7.

PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.

Gittelman MC, Hertzman B, Bailen J, Williams T, Koziol I, Henderson RJ, Efros M, Bidair M, Ward JF.

J Urol. 2013 Jul;190(1):64-9. doi: 10.1016/j.juro.2013.02.018. Epub 2013 Feb 14.

PMID:
23416644
[PubMed - indexed for MEDLINE]
8.

[Variation of urinary PCA3 following transrectal ultrasound-guided prostate biopsy].

Prezelin Y, Ronsin C, Celhay O, Pirès C, Doré B, Fromont G, Larré S, Irani J.

Prog Urol. 2011 Jun;21(6):412-6. doi: 10.1016/j.purol.2010.09.025. Epub 2010 Dec 16. French.

PMID:
21620302
[PubMed - indexed for MEDLINE]
9.

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.

Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM, Cancio AT, Desaulniers M, Ellis WJ, Rittenhouse H, Groskopf J.

Urology. 2007 Mar;69(3):532-5.

PMID:
17382159
[PubMed - indexed for MEDLINE]
10.

Biopsy and radical prostatectomy pathological patterns influence Prostate cancer gene 3 (PCA3) score.

De Luca S, Passera R, Bollito E, Milillo A, Scarpa RM, Papotti M, Coda R, Randone DF.

Anticancer Res. 2013 Oct;33(10):4657-62.

PMID:
24123045
[PubMed - indexed for MEDLINE]
11.

Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia.

Morote J, Rigau M, Garcia M, Mir C, Ballesteros C, Planas J, Raventós CX, Placer J, de Torres IM, Reventós J, Doll A.

World J Urol. 2010 Dec;28(6):677-80. doi: 10.1007/s00345-010-0580-0. Epub 2010 Jul 7.

PMID:
20607245
[PubMed - indexed for MEDLINE]
12.

Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases.

Crawford ED, Rove KO, Trabulsi EJ, Qian J, Drewnowska KP, Kaminetsky JC, Huisman TK, Bilowus ML, Freedman SJ, Glover WL Jr, Bostwick DG.

J Urol. 2012 Nov;188(5):1726-31. doi: 10.1016/j.juro.2012.07.023. Epub 2012 Sep 19.

PMID:
22998901
[PubMed - indexed for MEDLINE]
13.

Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy.

Scattoni V, Lazzeri M, Lughezzani G, De Luca S, Passera R, Bollito E, Randone D, Abdollah F, Capitanio U, Larcher A, Lista G, Gadda GM, Bini V, Montorsi F, Guazzoni G.

J Urol. 2013 Aug;190(2):496-501. doi: 10.1016/j.juro.2013.02.3184. Epub 2013 Mar 1.

PMID:
23466239
[PubMed - indexed for MEDLINE]
14.

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.

Nakanishi H, Groskopf J, Fritsche HA, Bhadkamkar V, Blase A, Kumar SV, Davis JW, Troncoso P, Rittenhouse H, Babaian RJ.

J Urol. 2008 May;179(5):1804-9; discussion 1809-10. doi: 10.1016/j.juro.2008.01.013. Epub 2008 Mar 18.

PMID:
18353398
[PubMed - indexed for MEDLINE]
15.

Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies.

San Francisco IF, Olumi AF, Kao J, Rosen S, DeWolf WC.

BJU Int. 2003 Mar;91(4):350-4.

PMID:
12603413
[PubMed - indexed for MEDLINE]
16.

The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting.

Adam A, Engelbrecht MJ, Bornman MS, Manda SO, Moshokoa E, Feilat RA.

BJU Int. 2011 Dec;108(11):1728-33. doi: 10.1111/j.1464-410X.2011.10202.x. Epub 2011 Apr 20.

PMID:
21507188
[PubMed - indexed for MEDLINE]
17.

PCA3: a molecular urine assay for predicting prostate biopsy outcome.

Deras IL, Aubin SM, Blase A, Day JR, Koo S, Partin AW, Ellis WJ, Marks LS, Fradet Y, Rittenhouse H, Groskopf J.

J Urol. 2008 Apr;179(4):1587-92. doi: 10.1016/j.juro.2007.11.038. Epub 2008 Mar 4.

PMID:
18295257
[PubMed - indexed for MEDLINE]
18.

Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsy.

Bollito E, De Luca S, Cicilano M, Passera R, Grande S, Maccagnano C, Cappia S, Milillo A, Montorsi F, Scarpa RM, Papotti M, Randone DF.

Anal Quant Cytol Histol. 2012 Apr;34(2):96-104.

PMID:
22611765
[PubMed - indexed for MEDLINE]
19.

Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.

Loeb S, Roehl KA, Yu X, Han M, Catalona WJ.

Urology. 2007 Jan;69(1):108-12.

PMID:
17270629
[PubMed - indexed for MEDLINE]
20.

Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer.

Wu AK, Reese AC, Cooperberg MR, Sadetsky N, Shinohara K.

Prostate Cancer Prostatic Dis. 2012 Mar;15(1):100-5. doi: 10.1038/pcan.2011.52. Epub 2011 Nov 1.

PMID:
22042252
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk